Core Laboratories Stock Forecast, Price & News

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 1 sell rating, 9 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Core Laboratories stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLB, but not buy additional shares or sell existing shares.
View analyst ratings for Core Laboratories or view top-rated stocks.

Wall Street analysts have given Core Laboratories a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Core Laboratories wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Core Laboratories is scheduled to release its next quarterly earnings announcement on Wednesday, April 28th 2021.
View our earnings forecast for Core Laboratories.

Core Laboratories (NYSE:CLB) released its quarterly earnings data on Tuesday, January, 26th. The oil and gas company reported $0.18 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.16 by $0.02. The oil and gas company had revenue of $113.80 million for the quarter, compared to analysts' expectations of $108.40 million. Core Laboratories had a negative net margin of 19.02% and a positive trailing twelve-month return on equity of 45.39%. Core Laboratories's quarterly revenue was down 27.4% on a year-over-year basis. During the same period in the previous year, the company posted $0.38 earnings per share.
View Core Laboratories' earnings history.

Core Laboratories' stock was trading at $10.93 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CLB shares have increased by 227.7% and is now trading at $35.82.
View which stocks have been most impacted by COVID-19.

Core Laboratories announced a quarterly dividend on Friday, January 15th. Shareholders of record on Monday, January 25th will be paid a dividend of $0.01 per share on Tuesday, February 16th. This represents a $0.04 annualized dividend and a yield of 0.11%. The ex-dividend date of this dividend is Friday, January 22nd.
View Core Laboratories' dividend history.

Core Laboratories pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.12%. Core Laboratories does not yet have a strock track record of dividend growth. The dividend payout ratio of Core Laboratories is 2.23%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Core Laboratories will have a dividend payout ratio of 4.65% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.
View Core Laboratories' dividend history.

12 brokerages have issued 12 month price targets for Core Laboratories' shares. Their forecasts range from $11.00 to $30.00. On average, they expect Core Laboratories' stock price to reach $21.22 in the next twelve months. This suggests that the stock has a possible downside of 40.8%.
View analysts' price targets for Core Laboratories or view top-rated stocks among Wall Street analysts.

60 employees have rated Core Laboratories CEO David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among Core Laboratories' employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Core Laboratories include Subsea 7 (SUBCY), RPC (RES), Liberty Oilfield Services (LBRT), Oceaneering International (OII), ProPetro (PUMP), NexTier Oilfield Solutions (NEX), National Energy Services Reunited (NESR), Frank's International (FI), Helix Energy Solutions Group (HLX), Select Energy Services (WTTR), North American Construction Group (NOA), Mammoth Energy Services (TUSK), Natural Gas Services Group (NGS), Nine Energy Service (NINE) and KLX Energy Services (KLXE).
View all of CLB's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD).

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Core Laboratories' stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (10.38%), Ariel Investments LLC (10.14%), Van ECK Associates Corp (2.35%), Fisher Asset Management LLC (1.99%), Douglas Lane & Associates LLC (1.50%) and Dimensional Fund Advisors LP (1.42%). Company insiders that own Core Laboratories stock include Gregory Barry Barnett, Jan Willem Sodderland, Kevin Daniels, Lawrence Bruno and Mark F Elvig.
View institutional ownership trends for Core Laboratories.

CLB stock was sold by a variety of institutional investors in the last quarter, including Truist Financial Corp, C Partners Holding GmbH, Principal Financial Group Inc., Principal Financial Group Inc., Morningstar Investment Services LLC, Renaissance Technologies LLC, Voloridge Investment Management LLC, and Sei Investments Co..
View insider buying and selling activity for Core Laboratories or view top insider-selling stocks.

CLB stock was purchased by a variety of institutional investors in the last quarter, including Ariel Investments LLC, Norges Bank, Van ECK Associates Corp, Douglas Lane & Associates LLC, BlackRock Inc., Edgestream Partners L.P., Lord Abbett & CO. LLC, and Eaton Vance Management. Company insiders that have bought Core Laboratories stock in the last two years include Gregory Barry Barnett, Jan Willem Sodderland, and Lawrence Bruno.
View insider buying and selling activity for Core Laboratories or or view top insider-buying stocks.

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CLB stock can currently be purchased for approximately $35.82.

Core Laboratories has a market capitalization of $1.60 billion and generates $668.21 million in revenue each year. The oil and gas company earns $101.98 million in net income (profit) each year or $1.79 on an earnings per share basis.

Core Laboratories employs 3,700 workers across the globe.

The official website for Core Laboratories is www.corelab.com.

Core Laboratories is headquartered at STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX.

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]